Genetic And Epigenetic Underpinnings Of Biological Aging: A Multi-Omics Study Integrating Mendelian Randomization, Spatial Transcriptomics, And Drug Target Discovery
Understanding why some individuals age faster or live longer than others is a complex puzzle. Recent research has taken a significant step forward by combining various types of biological information to unravel the molecular mechanisms behind biological aging and longevity. This approach, known as “multi-omics,” involves looking at different layers of biological data simultaneously, such as our genetic blueprint (genomics), how our genes are regulated (epigenetics), the activity of our genes (transcriptomics), and the small molecules involved in our metabolism (metabolomics).
To pinpoint cause-and-effect relationships, the researchers employed a technique called Mendelian randomization. This method uses natural genetic variations, which are randomly inherited, to determine if certain factors truly influence aging or longevity, rather than just being correlated. Additionally, by analyzing gene activity, including at the single-cell level, they gained a detailed understanding of which genes are active in specific cell types and how this activity changes with age.
This comprehensive investigation identified several new genes and biological pathways that are strongly linked to how our biological age progresses and how long we live. Importantly, the study also highlighted potential “druggable targets,” which are specific molecules that could be targeted by future medicines to influence the aging process. These findings offer crucial insights into the fundamental biology of aging and pave the way for developing new strategies to promote healthy aging and potentially extend human lifespan.
Source: link to paper